Patient info Open main menu

L01CE02 irinotecan

ATC group of level 5 – chemical substance · in plain English: cancer medicines

This site has the patient leaflet or the SPC of 8 medicines in this group.

Place in the ATC classification

  1. L Antineoplastic and immunomodulating agents 1,791 medicines
    1. L01 Antineoplastic agents 1,025 medicines
      1. L01C Plant alkaloids and other natural products, antineoplastic drugs 97 medicines
        1. L01CE Topoisomerase 1 (TOP1) inhibitors 17 medicines
          1. L01CE02 irinotecan 8 medicines

Active substances in the group

Medicines

MedicineLegal category
Campto 40 mg / 2 ml concentrate for solution for infusion SPC –
Irinotecan 1.5 mg / ml solution for infusion SPC –
Irinotecan 20 mg / ml concentrate for solution for infusion –
Irinotecan Hydrochloide 20 mg / ml concentrate for solution for infusion SPC –
Irinotecan Hydrochloride 20 mg / ml concentrate for solution for infusion SPC –
Irinotecan Hydrochloride Medac 20 mg / ml concentrate for solution for infusion SPC –
Onivyde pegylated liposomal (previously known as Onivyde) SPC –
Onivyde Pegylated liposomal 4.3 mg / ml concentrate for Dispersion for infusion SPC Prescription only (POM)

Other groups of the same level

Other names of the ATC group

Sources

  • Patient leaflets and SPCs: the MHRA product information (products.mhra.gov.uk) and the European Medicines Agency (EMA)
  • Active substances, ATC codes and legal categories: the NHS Dictionary of Medicines and Devices (dm+d), NHS Business Services Authority
  • World Health Organization (WHO): ATC/DDD classification, group L01CE02

Contains public sector information licensed under the Open Government Licence v3.0.

Ask your doctor or pharmacist which medicine is right for you.